How many clinical trials are tracked of favipiravir?

6 trials are tracked, 2 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

favipiravir

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of favipiravir

6 trials tracked of favipiravir: 3 in phase 3 or 4 and 2 with published results. The most-cited published study has 41 citations.

6Trials tracked

3Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 4 1 Phase 3 2 Phase 2 3

Phase 3 The Prevent Severe COVID-19 (PRESECO) Study Completed · 41 cited
Phase 4 Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients Completed · 10 cited
Phase 3 Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19 Completed
Phase 2 Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 Completed
Phase 2 Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19 Completed
Phase 2 Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.